7210 Wareham Drive, Tampa, FL 33647
June 24, 2025 Hims & Hers stock plummeted nearly 35% Monday after Novo Nordisk announced it was ending a collaboration to make its blockbuster weight-loss drug, Wegovy, available on Hims’ telehealth platform. Novo Nordisk said that Hims & Hers was breaking the law by continuing to sell copycat semaglutide, the key ingredient in Wegovy, alongside […]
Novo Nordisk Ends Wegovy Sales Deal With Hims & Hers Read More »
June 18, 2025 Following approval of its Plan of Reorganization, WW is on track to exit the court-supervised financial reorganization process as early as next week. “This is a meaningful turning point for WeightWatchers,” said Tara Comonte, CEO of Weight Watchers. “We’ve taken decisive action to significantly strengthen our financial foundation and will emerge with
Weight Watchers Reorganization Plan Confirmed Read More »
April 22, 2025 Marketdata LLC has just released a new market study: “The U.S. Meal Replacements Market: Retail & MLM Channels”, April 2025. This 77-page report analyses the meal replacements and retail appetite suppressants market in the U.S. The $5.1 billion U.S. meal replacements market has held up fairly well the past few years, despite
$5 Billion U.S. Meal Replacements Market Survives GLP-1s Competition Read More »
April 12, 2025 We noticed a post on Instagram today that pitches a company that will set up a medical weight loss program, using GLP-1 drugs for gyms. We shouldn’t be surprised. Everyone else has entered the GLP-1 gold rush, including med spas, so why not gyms as well? The company offering this “opportunity” is
Gyms Start Selling GLP-1 Drugs? The Bandwagon Gets More Crowded Read More »
April 9, 2025 (Reuters) – WW International may be preparing to file for bankruptcy in the coming months as part of a plan to hand control of the business to its creditors, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. Shares of the company tumbled nearly 59% to 18 cents
Weight Watchers Prepares for Possible Bankruptcy Filing Read More »
April 3, 2025 Premca Capital, an investment fund, has nominated three directors for election to WW International’s board, according to the people familiar with the matter. WW has a market capitalization of about $40 million, following a sharp decline in its shares in recent years. Its stock is down nearly 70% in the past year, due
Weight Watchers Investor Seeks Board Seats Read More »
April 2, 2025 Robard, the medical weight loss company, has begun selling its shakes, puddings, soups and beverages direct to the public via a new website. These products are part of its New Direction program. This is a departure from its long-standing policy where you had to sign up for the program to get access
Robard Begins Selling Diet Foods Direct to Consumers Read More »
March 31, 2025 Many economists and analysts are saying that a recession is coming sometime this year. That said, many weight loss companies and their top managers will say they’ll have to cut expenses, especially marketing. That’s the knee-jerk reaction, but it’s dead wrong. When consumers cut back on spending, they will revert to trusted
A Recession Is NOT The Time To Cut Marketing Read More »
March 24, 2025 Marketdata LLC has just published a new report: “The U.S. Weight Loss Market: Commercial (non-medical) Programs & Products”, March 2025. This is a 220-page analysis of commercial weight loss programs/companies and how they have been affected by and respond to the onslaught of the GLP-1 drugs competition. The $38 billion U.S. commercial weight loss
$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion Read More »
March 14, 2025 On Mar. 5, a judge denied a request from the Outsourcing Facilities Association (OFA), an industry group for compounding pharmacies, to block the FDA’s attempt to stop the production of compounded tirzepatide. Generally, making copies of brand-name drugs is not legal until their patents expire. But there are exceptions: Compounding pharmacies can
FDA Says No More Compounded Weight Loss Drugs – Industry OFA Appeal Shot Down Read More »